January 16, 2018 / 12:41 PM / 3 months ago

BRIEF-Centrexion Therapeutics Announces Fast Track Designation Granted By FDA To CNTX-4975 For Treatment Of Knee Osteoarthritis Pain

Jan 16 (Reuters) - Centrexion Therapeutics:

* CENTREXION THERAPEUTICS ANNOUNCES FAST TRACK DESIGNATION GRANTED BY FDA TO CNTX-4975 FOR TREATMENT OF KNEE OSTEOARTHRITIS PAIN Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below